A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor | NCT00796445 | Trialant

A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor | NCT00796445 | Trialant

Ages Eligible for Study: Adult (18-64)Older Adult (65+)
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Eligibility Criteria: Inclusion Criteria:

Written informed consent signed.

Male or female patient with histologically proven stage IIIB or IIIC cutaneous melanoma presenting with macroscopic lymph node involvement suitable for surgery.

The patient must have been surgically rendered free of disease before the randomization.

Patient is ≥ 18 years old at the time of signing the informed consent form.

The patient's lymph node tumor shows expression of the MAGE-A3 gene.

The patient has fully recovered from surgery.

ECOG performance status of 0 or 1 at the time of randomization.

The patient must have adequate organ functions as assessed by standard laboratory criteria.

If the patient is female, she must be of non-childbearing potential, or practice adequate contraception.

In the opinion of the investigator, the patient can and will comply with all the requirements of the protocol.

Exclusion Criteria:

The patient suffers from a mucosal or ocular melanoma.

The patient has or has had any history of in-transit metastases

The patient has been treated or is scheduled to be treated with an adjuvant anticancer therapy after the surgery that qualifies the patient for inclusion in the present trial.

The patient requires concomitant chronic treatment with systemic corticosteroids or any other immunosuppressive agents.

Use of any investigational or non-registered product (drug or vaccine) other than the study treatment.

The patient has a history of autoimmune disease.

The patient has a family history of congenital or hereditary immunodeficiency.

The patient is known to be positive for Human Immunodeficiency Virus (HIV) or has another confirmed or suspected immunosuppressive or immunodeficient condition.

History of allergic disease or reactions likely to be exacerbated by any component of the treatments.

The patient has psychiatric or addictive disorders that may compromise his/her ability to give informed consent or to comply with the trial procedures.

The patient has concurrent severe medical problems, unrelated to the malignancy, that would significantly limit full compliance with the study or expose the patient to unacceptable risk.

The patient has previous or concomitant malignancies at other sites, except effectively treated non-melanoma skin cancers or carcinoma in situ of the cervix or effectively treated malignancy that has been in remission for over 5 years and is highly likely to have been cured.

The patient has an uncontrolled bleeding disorder.

For female patients: the patient is pregnant or lactating.

GSK Investigational Site

Birmingham, Alabama 35243, United States

GSK Investigational Site

Tucson, Arizona 85724-5024, United States

GSK Investigational Site

Little Rock, Arkansas 72205, United States

GSK Investigational Site

La Jolla, California 92093-0987, United States

GSK Investigational Site

Los Angeles, California 90025, United States

GSK Investigational Site

Los Angeles, California 90095, United States

GSK Investigational Site

Orange, California 92868, United States

GSK Investigational Site

Riverside, California 92505, United States

GSK Investigational Site

San Francisco, California 94117-1079, United States

GSK Investigational Site

Santa Rosa, California 95403-1757, United States

GSK Investigational Site

Aurora, Colorado 80045, United States

GSK Investigational Site

Jacksonville, Florida 32204, United States

GSK Investigational Site

Jacksonville, Florida 32207, United States

GSK Investigational Site

Miami, Florida 33136-1002, United States

GSK Investigational Site

Orange Park, Florida 32073, United States

GSK Investigational Site

Orlando, Florida 32806, United States

GSK Investigational Site

Stuart, Florida 34994, United States

GSK Investigational Site

Atlanta, Georgia 30309, United States

GSK Investigational Site

Atlanta, Georgia 30322, United States

GSK Investigational Site

Chicago, Illinois 60611-2906, United States

GSK Investigational Site

Chicago, Illinois 60612-7323, United States

GSK Investigational Site

Chicago, Illinois 60612, United States

GSK Investigational Site

Chicago, Illinois 60637, United States

GSK Investigational Site

Indianapolis, Indiana 46202, United States

GSK Investigational Site

Louisville, Kentucky 40202, United States

GSK Investigational Site

Metairie, Louisiana 70006, United States

GSK Investigational Site

Baltimore, Maryland 21231, United States

GSK Investigational Site

Baltimore, Maryland 21237, United States

GSK Investigational Site

Boston, Massachusetts 02118, United States

GSK Investigational Site

Boston, Massachusetts 02215, United States

GSK Investigational Site

Ann Arbor, Michigan 48019, United States

GSK Investigational Site

Grand Rapids, Michigan 49503, United States

GSK Investigational Site

Fridley, Minnesota 55432, United States

GSK Investigational Site

Minneapolis, Minnesota 55455, United States

GSK Investigational Site

Saint Louis Park, Minnesota 55426, United States

GSK Investigational Site

St Louis, Missouri 63110, United States

GSK Investigational Site

Las Vegas, Nevada 89169, United States

GSK Investigational Site

Hackensack, New Jersey 07601, United States

GSK Investigational Site

Morristown, New Jersey 07962-1956, United States

GSK Investigational Site

Albany, New York 12206, United States

GSK Investigational Site

Latham, New York 12110, United States

GSK Investigational Site

New York, New York 10016, United States

GSK Investigational Site

Chapel Hill, North Carolina 27599-7305, United States

GSK Investigational Site

Charlotte, North Carolina 28204, United States

GSK Investigational Site

Durham, North Carolina 27710, United States

GSK Investigational Site

Winston-Salem, North Carolina 27157, United States

GSK Investigational Site

Cincinnati, Ohio 45219, United States

GSK Investigational Site

Cleveland, Ohio 44106, United States

GSK Investigational Site

Portland, Oregon 97213, United States

GSK Investigational Site

Philadelphia, Pennsylvania 19104, United States

GSK Investigational Site

Philadelphia, Pennsylvania 19107, United States

GSK Investigational Site

Philadelphia, Pennsylvania 19111, United States

GSK Investigational Site

Pittsburgh, Pennsylvania 15213-2584, United States

GSK Investigational Site

Sayre, Pennsylvania 18840, United States

GSK Investigational Site

Charleston, South Carolina 29406, United States

GSK Investigational Site

Charleston, South Carolina 29425, United States

GSK Investigational Site

Memphis, Tennessee 38104, United States

GSK Investigational Site

Nashville, Tennessee 37232-6307, United States

GSK Investigational Site

Amarillo, Texas 79106, United States

GSK Investigational Site

Austin, Texas 78759, United States

GSK Investigational Site

Bedford, Texas 76022, United States

GSK Investigational Site

Dallas, Texas 75230, United States

GSK Investigational Site

Dallas, Texas 75246, United States

GSK Investigational Site

Fort Worth, Texas 76104, United States

GSK Investigational Site

Houston, Texas 77030, United States

GSK Investigational Site

Lubbock, Texas 79410, United States

GSK Investigational Site

Plano, Texas 75093, United States

GSK Investigational Site

Tyler, Texas 75702, United States

GSK Investigational Site

Murray, Utah 84107, United States

GSK Investigational Site

Charlottesville, Virginia 22903, United States

GSK Investigational Site

Seattle, Washington 98109, United States

GSK Investigational Site

Vancouver, Washington 98684, United States

GSK Investigational Site

Morgantown, West Virginia 26506, United States

GSK Investigational Site

Milwaukee, Wisconsin 53215, United States

GSK Investigational Site

Ciudad Autónoma de Buenos Aires, Buenos Aires C1050AAK, Argentina

GSK Investigational Site

Cipolletti, Río Negro Province R8324EMB, Argentina

GSK Investigational Site

Rosario, Santa Fe Province S2000KZE, Argentina

GSK Investigational Site

Buenos Aires, C1121ABE, Argentina

GSK Investigational Site

Camperdown, New South Wales 2060, Australia

GSK Investigational Site

North Sydney, New South Wales 2060, Australia

GSK Investigational Site

Waratah, New South Wales 2298, Australia

GSK Investigational Site

Westmead, New South Wales 2145, Australia

GSK Investigational Site

Brisbane, Queensland 4102, Australia

GSK Investigational Site

Adelaide, South Australia 5000, Australia

GSK Investigational Site

Hobart, Tasmania 7000, Australia

GSK Investigational Site

East Melbourne, Victoria 3002, Australia

GSK Investigational Site

Heidelberg, Victoria 3084, Australia

GSK Investigational Site

Feldkirch, A-6800, Austria

GSK Investigational Site

Graz, A-8036, Austria

GSK Investigational Site

Linz, A-4010, Austria

GSK Investigational Site

Salzburg, A-5020, Austria

GSK Investigational Site

Vienna, A-1030, Austria

GSK Investigational Site

Vienna, A-1090, Austria

GSK Investigational Site

Vienna, A-1220, Austria

GSK Investigational Site

Wels, A-4600, Austria

GSK Investigational Site

Brussels, 1070, Belgium

GSK Investigational Site

Brussels, 1180, Belgium

GSK Investigational Site

Brussels, 1200, Belgium

GSK Investigational Site

Liège, 4000, Belgium

GSK Investigational Site

Wilrijk, 2610, Belgium

GSK Investigational Site

Belo Horizonte, Minas Gerais 30.140-001, Brazil

GSK Investigational Site

Porto Alegre, Rio Grande do Sul 90610-000, Brazil

GSK Investigational Site

São Paulo, 03102-002, Brazil

GSK Investigational Site

Plovdiv, 4000, Bulgaria

GSK Investigational Site

Sofia, 1756, Bulgaria

GSK Investigational Site

Winnipeg, Manitoba R3E 0V9, Canada

GSK Investigational Site

Ottawa, Ontario K1H 8L6, Canada

GSK Investigational Site

Brno, 656 53, Czechia

GSK Investigational Site

Hradec Králové, 500 05, Czechia

GSK Investigational Site

Ostrava, 708 52, Czechia

GSK Investigational Site

Prague, 100 34, Czechia

GSK Investigational Site

Prague, 128 08, Czechia

GSK Investigational Site

Tallinn, 13419, Estonia

GSK Investigational Site

Tartu, 51014, Estonia

GSK Investigational Site

Besançon, 25030, France

GSK Investigational Site

Bordeaux, 33075, France

GSK Investigational Site

Boulogne, 92104, France

GSK Investigational Site

Brest, 29609, France

GSK Investigational Site

Dijon, 21079, France

GSK Investigational Site

Grenoble, 38043, France

GSK Investigational Site

Le Mans, 72000, France

GSK Investigational Site

Lille, 59037, France

GSK Investigational Site

Limoges, 87042, France

GSK Investigational Site

Marseille, 13385, France

GSK Investigational Site

Montpellier, 34295, France

GSK Investigational Site

Nantes, 44093, France

GSK Investigational Site

Nice, 06202, France

GSK Investigational Site

Paris, 75006, France

GSK Investigational Site

Paris, 75018, France

GSK Investigational Site

Paris, 75475, France

GSK Investigational Site

Pierre-Bénite, 69495, France

GSK Investigational Site

Poitiers, 86021, France

GSK Investigational Site

Reims, 51092, France

GSK Investigational Site

Rennes, 35042, France

GSK Investigational Site

Rouen, 76031, France

GSK Investigational Site

Saint-Etienne, 42055, France

GSK Investigational Site

Toulouse, 31059, France

GSK Investigational Site

Tours, 37044, France

GSK Investigational Site

Villejuif, 94805, France

GSK Investigational Site

Freiburg im Breisgau, Baden-Wurttemberg 79104, Germany

GSK Investigational Site

Heidelberg, Baden-Wurttemberg 69120, Germany

GSK Investigational Site

Mannheim, Baden-Wurttemberg 68167, Germany

GSK Investigational Site

Tübingen, Baden-Wurttemberg 72076, Germany

GSK Investigational Site

Ulm, Baden-Wurttemberg 89081, Germany

GSK Investigational Site

Munich, Bavaria 80337, Germany

GSK Investigational Site

Munich, Bavaria 80802, Germany

GSK Investigational Site

Nuremberg, Bavaria 90419, Germany

GSK Investigational Site

Regensburg, Bavaria 93053, Germany

GSK Investigational Site

Würzburg, Bavaria 97080, Germany

GSK Investigational Site

Frankfurt am Main, Hesse 60590, Germany

GSK Investigational Site

Kassel, Hesse 34125, Germany

GSK Investigational Site

Marburg, Hesse 35033, Germany

GSK Investigational Site

Wiesbaden, Hesse 65191, Germany

GSK Investigational Site

Buxtehude, Lower Saxony 21614, Germany

GSK Investigational Site

Hanover, Lower Saxony 30625, Germany

GSK Investigational Site

Oldenburg, Lower Saxony 26133, Germany

GSK Investigational Site

Greifswald, Mecklenburg-Vorpommern 17475, Germany

GSK Investigational Site

Bonn, North Rhine-Westphalia 53127, Germany

GSK Investigational Site

Cologne, North Rhine-Westphalia 50937, Germany

GSK Investigational Site

Essen, North Rhine-Westphalia 45122, Germany

GSK Investigational Site

Minden, North Rhine-Westphalia 32429, Germany

GSK Investigational Site

Münster, North Rhine-Westphalia 48149, Germany

GSK Investigational Site

Ludwigshafen am Rhein, Rhineland-Palatinate 67063, Germany

GSK Investigational Site

Mainz, Rhineland-Palatinate 55131, Germany

GSK Investigational Site

Homburg, Saarland 66421, Germany

GSK Investigational Site

Dresden, Saxony 01307, Germany

GSK Investigational Site

Leipzig, Saxony 04103, Germany

GSK Investigational Site

Magdeburg, Saxony-Anhalt 39120, Germany

GSK Investigational Site

Quedlinburg, Saxony-Anhalt 06484, Germany

GSK Investigational Site

Kiel, Schleswig-Holstein 24105, Germany

GSK Investigational Site

Lübeck, Schleswig-Holstein 23538, Germany

GSK Investigational Site

Erfurt, Thuringia 99089, Germany

GSK Investigational Site

Jena, Thuringia 07740, Germany

GSK Investigational Site

Berlin, 10117, Germany

GSK Investigational Site

Berlin, 10249, Germany

GSK Investigational Site

Berlin, 13585, Germany

GSK Investigational Site

Athens, 11527, Greece

GSK Investigational Site

Athens, 185 47, Greece

GSK Investigational Site

Cork, Ireland

GSK Investigational Site

Dublin, 4, Ireland

GSK Investigational Site

Dublin, 7, Ireland

GSK Investigational Site

Dublin, 8, Ireland

GSK Investigational Site

Dublin, 9, Ireland

GSK Investigational Site

Galway, Co Galway, Ireland

GSK Investigational Site

Haifa, 31096, Israel

GSK Investigational Site

Petah Tikva, 49100, Israel

GSK Investigational Site

Ramat Gan, 52621, Israel

GSK Investigational Site

Bari, Apulia 70124, Italy

GSK Investigational Site

Naples, Campania 80131, Italy

GSK Investigational Site

Meldola (FC), Emilia-Romagna 47014, Italy

GSK Investigational Site

Modena, Emilia-Romagna 41124, Italy

GSK Investigational Site

Aviano (PN), Friuli Venezia Giulia 33081, Italy

GSK Investigational Site

Rome, Lazio 00144, Italy

GSK Investigational Site

Genoa, Liguria 16132, Italy

GSK Investigational Site

Milan, Lombardy 20133, Italy

GSK Investigational Site

Milan, Lombardy 20141, Italy

GSK Investigational Site

Pisa, Tuscany 56125, Italy

GSK Investigational Site

Siena, Tuscany 53100, Italy

GSK Investigational Site

Padova, Veneto 35128, Italy

GSK Investigational Site

Shizuoka, 411-8777, Japan

GSK Investigational Site

Tokyo, 104-0045, Japan

GSK Investigational Site

Monterrey, Nuevo León 64710, Mexico

GSK Investigational Site

Nijmegen, 6525 GA, Netherlands

GSK Investigational Site

Rotterdam, 3075 EA, Netherlands

GSK Investigational Site

Auckland, 0622, New Zealand

GSK Investigational Site

Christchurch, 8011, New Zealand

GSK Investigational Site

Wellington, 6021, New Zealand

GSK Investigational Site

Oslo, 0310, Norway

GSK Investigational Site

Bydgoszcz, 85-796, Poland

GSK Investigational Site

Gdansk, 80-215, Poland

GSK Investigational Site

Krakow, 31-108, Poland

GSK Investigational Site

Olsztyn, 10-228, Poland

GSK Investigational Site

Poznan, 61-866, Poland

GSK Investigational Site

Słupsk, 76-200, Poland

GSK Investigational Site

Warsaw, 02-781, Poland

GSK Investigational Site

Warsaw, 04-125, Poland

GSK Investigational Site

Baia Mare, 430031, Romania

GSK Investigational Site

Cluj-Napoca, Romania

GSK Investigational Site

Craiova, Dolj, 200535, Romania

GSK Investigational Site

Chelyabinsk, 454087, Russia

GSK Investigational Site

Kursk, 305035, Russia

GSK Investigational Site

Moscow, 115478, Russia

GSK Investigational Site

Omsk, 644013, Russia

GSK Investigational Site

Saint Petersburg, 197758, Russia

GSK Investigational Site

Saint Petersburg, 198255, Russia

GSK Investigational Site

Stavropol, 355047, Russia

GSK Investigational Site

Belgrade, 11 000, Serbia

GSK Investigational Site

Belgrade, Serbia

GSK Investigational Site

Kamenitz, 21204, Serbia

GSK Investigational Site

Seoul, 05505, South Korea

GSK Investigational Site

Seoul, 06351, South Korea

GSK Investigational Site

Barcelona, 08036, Spain

GSK Investigational Site

Madrid, 28040, Spain

GSK Investigational Site

Pamplona, 31008, Spain

GSK Investigational Site

Seville, 41009, Spain

GSK Investigational Site

Valencia, 46014, Spain

GSK Investigational Site

Gothenburg, SE-413 45, Sweden

GSK Investigational Site

Malmö, SE-205 20, Sweden

GSK Investigational Site

Uppsala, SE-751 85, Sweden

GSK Investigational Site

Basel, 4031, Switzerland

GSK Investigational Site

Zurich, 8091, Switzerland

GSK Investigational Site

Kaohsiung City, 807, Taiwan

GSK Investigational Site

Taipei, 112, Taiwan

GSK Investigational Site

Taoyuan Hsien, 333, Taiwan

GSK Investigational Site

Dnipropetrovsk, 49100, Ukraine

GSK Investigational Site

Dnipropetrovsk, 49102, Ukraine

GSK Investigational Site

Donetsk, 83092, Ukraine

GSK Investigational Site

Kryvyi Rih, 50048, Ukraine

GSK Investigational Site

Kyiv, 03022, Ukraine

GSK Investigational Site

Lviv, 79031, Ukraine

GSK Investigational Site

Chelmsford, Essex CM1 7ET, United Kingdom

GSK Investigational Site

Belfast, Northern Ireland, BT9 7AB, United Kingdom

GSK Investigational Site

Colchester, CO3 3NB, United Kingdom

GSK Investigational Site

Dundee, DD1 9SY, United Kingdom

GSK Investigational Site

London, SW17 0RE, United Kingdom

GSK Investigational Site

Poole, Dorset, BH15 2JB, United Kingdom

GSK Investigational Site

Salisbury, SP2 8BJ, United Kingdom